In the last 12 months, insiders at AN2 Therapeutics, Inc. ($ANTX) filed 264 transactions with the SEC: 23 open-market purchases totaling $18,117,907 and 70 sales totaling $17,208,983. Net insider sentiment: net buying.
AN2 Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- RA CAPITAL MANAGEMENT, L.P. (TenPercentOwner) — 1 transaction totaling $16,000,002
- Leonard Braden Michael (Not found) — 6 transactions totaling $4,650,477
- Aziz Kabeer (Not found) — 32 transactions totaling $3,976,729
- Adjuvant Global Health Technology Fund, L.P. (Not found) — 20 transactions totaling $3,976,729
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 2 transactions totaling $3,807,102
View all SEC Filings for AN2 Therapeutics, Inc. (ANTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | FitzPatrick Margaret M | Not found | D | Stock Option (right to buy) | 11463 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.04% |
| March 19, 2026 | FitzPatrick Margaret M | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | FitzPatrick Margaret M | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | FitzPatrick Margaret M | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Easom Eric | Chief Executive Officer | D | Stock Option (right to buy) | 267650 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.88% |
| March 19, 2026 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 267650 | $0.00 | 267,650.0000 | 30,276,230 | 9999.99% | 0.88% |
| March 19, 2026 | Easom Eric | Chief Executive Officer | D | Stock Option (right to buy) | 225000 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.74% |
| March 19, 2026 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 225000 | $0.00 | 225,000.0000 | 30,276,230 | 9999.99% | 0.74% |
| March 19, 2026 | Easom Eric | Chief Executive Officer | D | Stock Option (right to buy) | 249999 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.83% |
| March 19, 2026 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 249999 | $0.00 | 249,999.0000 | 30,276,230 | 9999.99% | 0.83% |
| March 19, 2026 | Readnour Robin Shane | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Readnour Robin Shane | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Readnour Robin Shane | Not found | D | Stock Option (right to buy) | 20724 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.07% |
| March 19, 2026 | Readnour Robin Shane | Not found | A | Stock Option (right to buy) | 20724 | $0.00 | 20,724.0000 | 30,276,230 | 9999.99% | 0.07% |
| March 19, 2026 | Spigelman Melvin K | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Spigelman Melvin K | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Spigelman Melvin K | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | Spigelman Melvin K | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | Spigelman Melvin K | Not found | D | Stock Option (right to buy) | 16941 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.06% |
| March 19, 2026 | Spigelman Melvin K | Not found | A | Stock Option (right to buy) | 16941 | $0.00 | 16,941.0000 | 30,276,230 | 9999.99% | 0.06% |
| March 19, 2026 | Eizen Joshua M | See Remarks | D | Stock Option (right to buy) | 50150 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.17% |
| March 19, 2026 | Eizen Joshua M | See Remarks | A | Stock Option (right to buy) | 50150 | $0.00 | 50,150.0000 | 30,276,230 | 9999.99% | 0.17% |
| March 19, 2026 | Eizen Joshua M | See Remarks | D | Stock Option (right to buy) | 92000 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.30% |
| March 19, 2026 | Eizen Joshua M | See Remarks | A | Stock Option (right to buy) | 92000 | $0.00 | 92,000.0000 | 30,276,230 | 9999.99% | 0.30% |
| March 19, 2026 | Zakrzewski Joseph S | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Zakrzewski Joseph S | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Zakrzewski Joseph S | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | Zakrzewski Joseph S | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | Zakrzewski Joseph S | Not found | D | Stock Option (right to buy) | 99999 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.33% |
| March 19, 2026 | Zakrzewski Joseph S | Not found | A | Stock Option (right to buy) | 99999 | $0.00 | 99,999.0000 | 30,276,230 | 9999.99% | 0.33% |
| March 19, 2026 | Wong Stephanie | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Wong Stephanie | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Wong Stephanie | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | Wong Stephanie | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | Wong Stephanie | Not found | D | Stock Option (right to buy) | 24999 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Wong Stephanie | Not found | A | Stock Option (right to buy) | 24999 | $0.00 | 24,999.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 73665 | $0.00 | 73,665.0000 | 30,276,230 | 9999.99% | 0.24% |
| March 19, 2026 | Day Lucy | Chief Financial Officer | D | Stock Option (right to buy) | 73665 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.24% |
| March 19, 2026 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 66000 | $0.00 | 66,000.0000 | 30,276,230 | 9999.99% | 0.22% |
| March 19, 2026 | Day Lucy | Chief Financial Officer | D | Stock Option (right to buy) | 66000 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.22% |
| March 19, 2026 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 82300 | $0.00 | 82,300.0000 | 30,276,230 | 9999.99% | 0.27% |
| March 19, 2026 | Day Lucy | Chief Financial Officer | D | Stock Option (right to buy) | 82300 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.27% |
| March 19, 2026 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 66000 | $0.00 | 66,000.0000 | 30,276,230 | 9999.99% | 0.22% |
| March 19, 2026 | Chanda Sanjay | Chief Development Officer | D | Stock Option (right to buy) | 66000 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.22% |
| March 19, 2026 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 57950 | $0.00 | 57,950.0000 | 30,276,230 | 9999.99% | 0.19% |
| March 19, 2026 | Chanda Sanjay | Chief Development Officer | D | Stock Option (right to buy) | 57950 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.19% |
| March 19, 2026 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 41665 | $0.00 | 41,665.0000 | 30,276,230 | 9999.99% | 0.14% |
| March 19, 2026 | Chanda Sanjay | Chief Development Officer | D | Stock Option (right to buy) | 41665 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.14% |
| March 19, 2026 | Marks Gilbert Lynn | Not found | A | Stock Option (right to buy) | 10665 | $0.00 | 10,665.0000 | 30,276,230 | 9999.99% | 0.04% |
| March 19, 2026 | Marks Gilbert Lynn | Not found | D | Stock Option (right to buy) | 10665 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.04% |
| March 19, 2026 | Marks Gilbert Lynn | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | Marks Gilbert Lynn | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | Marks Gilbert Lynn | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Marks Gilbert Lynn | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Aziz Kabeer | Not found | A | Stock Option (right to buy) | 20724 | $0.00 | 20,724.0000 | 30,276,230 | 9999.99% | 0.07% |
| March 19, 2026 | Aziz Kabeer | Not found | D | Stock Option (right to buy) | 20724 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.07% |
| March 19, 2026 | Aziz Kabeer | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Aziz Kabeer | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Martin Patricia A. | Not found | A | Stock Option (right to buy) | 24999 | $0.00 | 24,999.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Martin Patricia A. | Not found | D | Stock Option (right to buy) | 24999 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | Martin Patricia A. | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | Martin Patricia A. | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | Martin Patricia A. | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | Martin Patricia A. | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | FitzPatrick Margaret M | Not found | A | Stock Option (right to buy) | 11463 | $0.00 | 11,463.0000 | 30,276,230 | 9999.99% | 0.04% |
| March 19, 2026 | FitzPatrick Margaret M | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 3, 2026 | Williams Sarah Joanne | Principal Accounting Officer | S | Common Stock | 327 | $1.06 | 66,848.0000 | 30,276,230 | 0.49% | 0.00% |
| Feb. 20, 2026 | Aziz Kabeer | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Zakrzewski Joseph S | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Spigelman Melvin K | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Eizen Joshua M | See Remarks | A | Common Stock | 50000 | $0.00 | 207,499.0000 | 30,276,230 | 31.75% | 0.17% |
| Feb. 20, 2026 | Eizen Joshua M | See Remarks | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 30,276,230 | 9999.99% | 0.33% |
| Feb. 20, 2026 | Day Lucy | Chief Financial Officer | A | Common Stock | 38000 | $0.00 | 118,363.0000 | 30,276,230 | 47.29% | 0.13% |
| Feb. 20, 2026 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 77000 | $0.00 | 77,000.0000 | 30,276,230 | 50.00% | 0.25% |
| Feb. 20, 2026 | Williams Sarah Joanne | Principal Accounting Officer | A | Common Stock | 48375 | $0.00 | 67,175.0000 | 30,276,230 | 257.31% | 0.16% |
| Feb. 20, 2026 | Easom Eric | Chief Executive Officer | A | Common Stock | 112250 | $0.00 | 1,628,512.0000 | 30,276,230 | 7.40% | 0.37% |
| Feb. 20, 2026 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 224500 | $0.00 | 224,500.0000 | 30,276,230 | 9999.99% | 0.74% |
| Feb. 20, 2026 | Marks Gilbert Lynn | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Readnour Robin Shane | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Wong Stephanie | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Martin Patricia A. | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Chanda Sanjay | Chief Development Officer | A | Common Stock | 38000 | $0.00 | 118,823.0000 | 30,276,230 | 47.02% | 0.13% |
| Feb. 20, 2026 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 77000 | $0.00 | 77,000.0000 | 30,276,230 | 9999.99% | 0.25% |
| Jan. 12, 2026 | Aziz Kabeer | Not found | A | Common Stock | 11560 | $0.00 | 2,425,979.0000 | 30,276,230 | 0.48% | 0.04% |
| Jan. 12, 2026 | Martin Patricia A. | Not found | A | Common Stock | 3650 | $0.00 | 16,905.0000 | 30,276,230 | 27.54% | 0.01% |
| Jan. 12, 2026 | Marks Gilbert Lynn | Not found | A | Common Stock | 11560 | $0.00 | 75,309.0000 | 30,276,230 | 18.13% | 0.04% |
| Jan. 6, 2026 | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 2858 | $1.01 | 59,086.0000 | 30,276,230 | 4.61% | 0.01% |
| Jan. 5, 2026 | Chanda Sanjay | Chief Development Officer | S | Common Stock | 3295 | $1.00 | 81,779.0000 | 30,276,230 | 3.87% | 0.01% |
| Jan. 5, 2026 | Day Lucy | Chief Financial Officer | S | Common Stock | 3295 | $1.00 | 80,875.0000 | 30,276,230 | 3.91% | 0.01% |
| Jan. 5, 2026 | Eizen Joshua M | See Remarks | S | Common Stock | 17923 | $1.00 | 159,430.0000 | 30,276,230 | 10.11% | 0.06% |
| Jan. 6, 2026 | Eizen Joshua M | See Remarks | S | Common Stock | 6931 | $1.01 | 152,499.0000 | 30,276,230 | 4.35% | 0.02% |
| Jan. 6, 2026 | Chanda Sanjay | Chief Development Officer | S | Common Stock | 5956 | $1.01 | 75,823.0000 | 30,276,230 | 7.28% | 0.02% |
| Jan. 6, 2026 | Day Lucy | Chief Financial Officer | S | Common Stock | 5512 | $1.01 | 75,363.0000 | 30,276,230 | 6.82% | 0.02% |
| Jan. 5, 2026 | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 3604 | $1.00 | 61,944.0000 | 30,276,230 | 5.50% | 0.01% |
| Nov. 4, 2025 | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 765 | $1.14 | 65,548.0000 | 30,276,230 | 1.15% | 0.00% |
| Nov. 4, 2025 | Eizen Joshua M | See Remarks | S | Common Stock | 2819 | $1.14 | 177,353.0000 | 30,276,230 | 1.56% | 0.01% |
| Oct. 10, 2025 | Martin Patricia A. | Not found | A | Common Stock | 3274 | $0.00 | 13,255.0000 | 30,276,230 | 32.80% | 0.01% |
| Oct. 10, 2025 | Marks Gilbert Lynn | Not found | A | Common Stock | 10367 | $0.00 | 63,749.0000 | 30,276,230 | 19.42% | 0.03% |
| Oct. 10, 2025 | Aziz Kabeer | Not found | A | Common Stock | 10367 | $0.00 | 2,414,419.0000 | 30,276,230 | 0.43% | 0.03% |
| July 10, 2025 | Aziz Kabeer | Not found | A | Common Stock | 11875 | $0.00 | 2,404,052.0000 | 29,828,227 | 0.50% | 0.04% |
| July 10, 2025 | Marks Gilbert Lynn | Not found | A | Common Stock | 11875 | $0.00 | 53,382.0000 | 29,828,227 | 28.61% | 0.04% |
| July 10, 2025 | Martin Patricia A. | Not found | A | Common Stock | 3750 | $0.00 | 9,981.0000 | 29,828,227 | 60.18% | 0.01% |
| May 28, 2025 | Leonard Braden Michael | Not found | S | Common Stock | 200000 | $1.09 | 3,017,432.0000 | 29,828,227 | 6.22% | 0.67% |
| June 2, 2025 | Easom Eric | Chief Executive Officer | P | Common Stock | 10000 | $1.07 | 1,516,262.0000 | 29,828,227 | 0.66% | 0.03% |
| May 30, 2025 | Leonard Braden Michael | Not found | S | Common Stock | 7000 | $1.03 | 3,217,432.0000 | 29,828,227 | 0.22% | 0.02% |
| May 30, 2025 | Leonard Braden Michael | Not found | S | Common Stock | 425000 | $1.01 | 3,224,432.0000 | 29,828,227 | 11.65% | 1.42% |
| May 28, 2025 | Leonard Braden Michael | Not found | S | Common Stock | 100000 | $1.16 | 3,649,432.0000 | 29,828,227 | 2.67% | 0.34% |
| May 28, 2025 | Leonard Braden Michael | Not found | S | Common Stock | 2000000 | $1.16 | 3,749,432.0000 | 29,828,227 | 34.79% | 6.71% |
| May 28, 2025 | FitzPatrick Margaret M | Not found | P | Common Stock | 8610 | $1.18 | 8,610.0000 | 29,828,227 | 9999.99% | 0.03% |
| May 22, 2025 | Spigelman Melvin K | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | Martin Patricia A. | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | Readnour Robin Shane | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | Aziz Kabeer | Not found | A | Stock Optin (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | Marks Gilbert Lynn | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | Wong Stephanie | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| May 22, 2025 | Zakrzewski Joseph S | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| April 10, 2025 | Marks Gilbert Lynn | Not found | A | Common Stock | 9705 | $0.00 | 41,507.0000 | 29,828,227 | 30.52% | 0.03% |
| April 10, 2025 | Martin Patricia A. | Not found | A | Common Stock | 3065 | $0.00 | 6,231.0000 | 29,828,227 | 96.81% | 0.01% |
| April 10, 2025 | Aziz Kabeer | Not found | A | Common Stock | 9705 | $0.00 | 2,392,177.0000 | 29,828,227 | 0.41% | 0.03% |
| April 10, 2025 | Zakrzewski Joseph S | Not found | A | Common Stock | 10523 | $0.00 | 551,418.0000 | 29,828,227 | 1.95% | 0.04% |
| Feb. 26, 2025 | Prior Stephen David | Chief Strategy Officer | A | Stock Option (right to buy) | 56000 | $0.00 | 56,000.0000 | 29,828,227 | 9999.99% | 0.19% |
| Feb. 26, 2025 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 290500 | $0.00 | 290,500.0000 | 29,828,227 | 9999.99% | 0.97% |
| Feb. 26, 2025 | Easom Eric | Chief Executive Officer | A | Common Stock | 145250 | $0.00 | 1,506,262.0000 | 29,828,227 | 10.67% | 0.49% |
| Feb. 26, 2025 | Eizen Joshua M | See Remarks | A | Stock Option (right to buy) | 117000 | $0.00 | 117,000.0000 | 29,828,227 | 9999.99% | 0.39% |
| Feb. 26, 2025 | Eizen Joshua M | See Remarks | A | Common Stock | 58500 | $0.00 | 175,172.0000 | 29,828,227 | 50.14% | 0.20% |
| Feb. 26, 2025 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 93000 | $0.00 | 93,000.0000 | 29,828,227 | 50.00% | 0.31% |
| Feb. 26, 2025 | Day Lucy | Chief Financial Officer | A | Common Stock | 46500 | $0.00 | 79,170.0000 | 29,828,227 | 142.33% | 0.16% |
| Feb. 26, 2025 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 100500 | $0.00 | 100,500.0000 | 29,828,227 | 9999.99% | 0.34% |
| Feb. 26, 2025 | Chanda Sanjay | Chief Development Officer | A | Common Stock | 50250 | $0.00 | 80,074.0000 | 29,828,227 | 168.49% | 0.17% |
| Feb. 26, 2025 | Prior Stephen David | Chief Strategy Officer | A | Common Stock | 28000 | $0.00 | 61,313.0000 | 29,828,227 | 84.05% | 0.09% |
| Jan. 3, 2025 | Chanda Sanjay | Chief Development Officer | S | Common Stock | 2957 | $1.34 | 29,824.0000 | 29,828,227 | 9.02% | 0.01% |
| Jan. 3, 2025 | Day Lucy | Chief Financial Officer | S | Common Stock | 2957 | $1.34 | 32,670.0000 | 29,828,227 | 8.30% | 0.01% |
| Jan. 3, 2025 | Prior Stephen David | Chief Strategy Officer | S | Common Stock | 2029 | $1.34 | 33,313.0000 | 29,828,227 | 5.74% | 0.01% |
| Jan. 3, 2025 | Eizen Joshua M | See Remarks | S | Common Stock | 9663 | $1.34 | 116,672.0000 | 29,828,227 | 7.65% | 0.03% |
| Dec. 19, 2024 | Zakrzewski Joseph S | Not found | A | Common Stock | 9816 | $0.00 | 540,895.0000 | 29,841,169 | 1.85% | 0.03% |
| Dec. 19, 2024 | Marks Gilbert Lynn | Not found | A | Common Stock | 8972 | $0.00 | 31,802.0000 | 29,841,169 | 39.30% | 0.03% |
| Dec. 19, 2024 | Aziz Kabeer | Not found | A | Common Stock | 8972 | $0.00 | 2,382,472.0000 | 29,841,169 | 0.38% | 0.03% |
| Dec. 19, 2024 | Martin Patricia A. | Not found | A | Common Stock | 3166 | $0.00 | 3,166.0000 | 29,841,169 | 9999.99% | 0.01% |
| Dec. 19, 2024 | Readnour Robin Shane | Not found | A | Common Stock | 9077 | $0.00 | 1,243,938.0000 | 29,841,169 | 0.74% | 0.03% |
| Dec. 9, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 12289 | $1.43 | 577,288.0000 | 29,841,169 | 2.18% | 0.04% |
| Dec. 10, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 5000 | $1.49 | 582,288.0000 | 29,841,169 | 0.87% | 0.02% |
| Dec. 10, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 5000 | $1.49 | 652,573.0000 | 29,841,169 | 0.77% | 0.02% |
| Dec. 6, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 12711 | $1.45 | 564,999.0000 | 29,841,169 | 2.30% | 0.04% |
| Dec. 6, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 6517 | $1.45 | 629,090.0000 | 29,841,169 | 1.05% | 0.02% |
| Dec. 9, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 18483 | $1.43 | 647,573.0000 | 29,841,169 | 2.94% | 0.06% |
| Nov. 27, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 25000 | $1.42 | 622,573.0000 | 29,841,169 | 4.18% | 0.08% |
| Nov. 27, 2024 | Zakrzewski Joseph S | Not found | P | Common Stock | 2000 | $1.40 | 531,079.0000 | 29,841,169 | 0.38% | 0.01% |
| Nov. 27, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 25000 | $1.42 | 552,288.0000 | 29,841,169 | 4.74% | 0.08% |
| Nov. 26, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 12500 | $1.39 | 597,573.0000 | 29,841,169 | 2.14% | 0.04% |
| Nov. 26, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 12500 | $1.39 | 527,288.0000 | 29,841,169 | 2.43% | 0.04% |
| Nov. 20, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 25000 | $1.16 | 585,073.0000 | 29,841,169 | 4.46% | 0.08% |
| Nov. 19, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 75000 | $1.03 | 560,073.0000 | 29,841,169 | 15.46% | 0.25% |
| Nov. 20, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 25000 | $1.15 | 514,788.0000 | 29,841,169 | 5.10% | 0.08% |
| Nov. 19, 2024 | Readnour Robin Shane | Not found | P | Common Stock | 75000 | $1.04 | 489,788.0000 | 29,841,169 | 18.08% | 0.25% |
| Nov. 18, 2024 | Zakrzewski Joseph S | Not found | P | Common Stock | 20000 | $1.00 | 524,079.0000 | 29,841,169 | 3.97% | 0.07% |
| Nov. 19, 2024 | Zakrzewski Joseph S | Not found | P | Common Stock | 5000 | $1.01 | 529,079.0000 | 29,841,169 | 0.95% | 0.02% |
| Nov. 18, 2024 | Easom Eric | Chief Executive Officer | P | Common Stock | 50000 | $1.00 | 1,361,012.0000 | 29,841,169 | 3.81% | 0.17% |
| Nov. 4, 2024 | Prior Stephen David | Chief Strategy Officer | A | Common Stock | 10125 | $0.00 | 35,342.0000 | 29,841,169 | 40.15% | 0.03% |
| Nov. 4, 2024 | Eizen Joshua M | See Remarks | A | Stock Option (right to buy) | 63000 | $0.00 | 63,000.0000 | 29,841,169 | 9999.99% | 0.21% |
| Nov. 4, 2024 | Eizen Joshua M | See Remarks | A | Common Stock | 31500 | $0.00 | 126,335.0000 | 29,841,169 | 33.22% | 0.11% |
| Nov. 4, 2024 | Prior Stephen David | Chief Strategy Officer | A | Stock Option (right to buy) | 20250 | $0.00 | 20,250.0000 | 29,841,169 | 9999.99% | 0.07% |
| Aug. 14, 2024 | Leonard Braden Michael | Not found | P | Common Stock | 1500000 | $1.04 | 5,749,432.0000 | 23,600,107 | 35.30% | 6.36% |
| Aug. 9, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 114759 | $1.08 | 300,853.0000 | 23,600,107 | 27.61% | 0.49% |
| Aug. 9, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | S | Common Stock | 3410335 | $1.08 | 1,725,348.0000 | 23,600,107 | 66.40% | 14.45% |
| July 10, 2024 | Eizen Joshua M | Chief Legal Officer | A | Common Stock | 60000 | $0.00 | 94,833.0000 | 23,600,107 | 172.25% | 0.25% |
| June 19, 2024 | Spigelman Melvin K | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | Martin Patricia A. | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | Wong Stephanie | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | Aziz Kabeer | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | Marks Gilbert Lynn | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | Readnour Robin Shane | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| June 19, 2024 | Zakrzewski Joseph S | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| March 15, 2024 | Eckburg Paul | Chief Medical Officer | A | Common Stock | 30000 | $0.00 | 51,416.0000 | 23,600,107 | 140.08% | 0.13% |
| March 15, 2024 | Krause Kevin Michael | Chief Strategy Officer | A | Common Stock | 30000 | $0.00 | 31,914.0000 | 23,600,107 | 1567.40% | 0.13% |
| March 15, 2024 | Eizen Joshua M | Chief Legal Officer | A | Common Stock | 30000 | $0.00 | 32,447.0000 | 23,600,107 | 1225.99% | 0.13% |
| March 15, 2024 | Day Lucy | Chief Financial Officer | A | Common Stock | 27500 | $0.00 | 30,627.0000 | 23,600,107 | 879.44% | 0.12% |
| March 15, 2024 | Easom Eric | Chief Executive Officer | A | Common Stock | 99000 | $0.00 | 101,130.0000 | 23,600,107 | 4647.89% | 0.42% |
| March 15, 2024 | Chanda Sanjay | Chief Development Officer | A | Common Stock | 27500 | $0.00 | 28,235.0000 | 23,600,107 | 3741.50% | 0.12% |
| March 15, 2024 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 23,600,107 | 9999.99% | 0.23% |
| March 15, 2024 | Eizen Joshua M | Chief Legal Officer | A | Common Stock | 30000 | $0.00 | 32,447.0000 | 23,600,107 | 1225.99% | 0.13% |
| March 15, 2024 | Eizen Joshua M | Chief Legal Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 23,600,107 | 9999.99% | 0.25% |
| March 15, 2024 | Day Lucy | Chief Financial Officer | A | Common Stock | 27500 | $0.00 | 30,627.0000 | 23,600,107 | 879.44% | 0.12% |
| March 15, 2024 | Krause Kevin Michael | Chief Strategy Officer | A | Common Stock | 30000 | $0.00 | 31,914.0000 | 23,600,107 | 1567.40% | 0.13% |
| March 15, 2024 | Krause Kevin Michael | Chief Strategy Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 23,600,107 | 9999.99% | 0.25% |
| March 15, 2024 | Chanda Sanjay | Chief Development Officer | A | Common Stock | 27500 | $0.00 | 28,235.0000 | 23,600,107 | 3741.50% | 0.12% |
| March 15, 2024 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 23,600,107 | 9999.99% | 0.23% |
| March 15, 2024 | Eckburg Paul | Chief Medical Officer | A | Common | 30000 | $0.00 | 51,416.0000 | 23,600,107 | 140.08% | 0.13% |
| March 15, 2024 | Eckburg Paul | Chief Medical Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 23,600,107 | 9999.99% | 0.25% |
| March 15, 2024 | Easom Eric | Chief Executive Officer | A | Common Stock | 99000 | $0.00 | 1,311,012.0000 | 23,600,107 | 8.17% | 0.42% |
| March 15, 2024 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 198000 | $0.00 | 198,000.0000 | 23,600,107 | 9999.99% | 0.84% |
| Jan. 18, 2024 | Zakrzewski Joseph S | Not found | S | Common Stock | 100000 | $19.11 | 504,079.0000 | 23,600,107 | 16.55% | 0.42% |
| Jan. 16, 2024 | Aziz Kabeer | Not found | S | Common Stock | 84093 | $19.65 | 2,373,500.0000 | 23,600,107 | 3.42% | 0.36% |
| Jan. 16, 2024 | Aziz Kabeer | Not found | S | Common Stock | 15907 | $19.65 | 2,373,500.0000 | 23,600,107 | 0.67% | 0.07% |
| Jan. 16, 2024 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 84093 | $19.65 | 2,373,500.0000 | 23,600,107 | 3.42% | 0.36% |
| Jan. 16, 2024 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 15907 | $19.65 | 2,373,500.0000 | 23,600,107 | 0.67% | 0.07% |
| Jan. 12, 2024 | Readnour Robin Shane | Director | S | Common Stock | 706 | $21.92 | 414,788.0000 | 23,600,107 | 0.17% | 0.00% |
| Jan. 12, 2024 | Readnour Robin Shane | Director | S | Common Stock | 719 | $21.91 | 485,073.0000 | 23,600,107 | 0.15% | 0.00% |
| Jan. 10, 2024 | Readnour Robin Shane | Director | S | Common Stock | 1869 | $21.93 | 415,494.0000 | 23,600,107 | 0.45% | 0.01% |
| Jan. 10, 2024 | Readnour Robin Shane | Director | S | Common Stock | 1800 | $21.92 | 485,792.0000 | 23,600,107 | 0.37% | 0.01% |
| Jan. 9, 2024 | Krause Kevin Michael | Chief Strategy Officer | M | Stock Option (right to buy) | 2417 | $0.00 | 49,868.0000 | 23,600,107 | 4.62% | 0.01% |
| Jan. 9, 2024 | Krause Kevin Michael | Chief Strategy Officer | M | Common Stock | 2417 | $0.42 | 4,331.0000 | 23,600,107 | 126.28% | 0.01% |
| Jan. 9, 2024 | Krause Kevin Michael | Chief Strategy Officer | M | Common Stock | 5000 | $6.60 | 9,331.0000 | 23,600,107 | 115.45% | 0.02% |
| Jan. 9, 2024 | Krause Kevin Michael | Chief Strategy Officer | S | Common Stock | 7417 | $20.14 | 1,914.0000 | 23,600,107 | 79.49% | 0.03% |
| Jan. 9, 2024 | Krause Kevin Michael | Chief Strategy Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 26,832.0000 | 23,600,107 | 15.71% | 0.02% |
| Jan. 2, 2024 | Easom Eric | Chief Executive Officer | S | Common Stock | 2777 | $20.09 | 1,212,012.0000 | 23,600,107 | 0.23% | 0.01% |
| Jan. 2, 2024 | Krause Kevin Michael | Chief Strategy Officer | M | Stock Option (right to buy) | 2583 | $0.00 | 52,285.0000 | 23,600,107 | 4.71% | 0.01% |
| Jan. 2, 2024 | Krause Kevin Michael | Chief Strategy Officer | S | Common Stock | 2583 | $20.12 | 1,914.0000 | 23,600,107 | 57.44% | 0.01% |
| Jan. 2, 2024 | Krause Kevin Michael | Chief Strategy Officer | M | Common Stock | 2583 | $0.42 | 4,497.0000 | 23,600,107 | 134.95% | 0.01% |
| Nov. 14, 2023 | Aziz Kabeer | Not found | S | Common Stock | 288 | $16.15 | 2,473,500.0000 | 0 | 0.01% | 0.00% |
| Nov. 14, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 1522 | $16.15 | 2,473,500.0000 | 0 | 0.06% | 0.00% |
| Nov. 14, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 288 | $16.15 | 2,473,500.0000 | 0 | 0.01% | 0.00% |
| Nov. 14, 2023 | Aziz Kabeer | Not found | S | Common Stock | 1522 | $16.15 | 2,473,500.0000 | 0 | 0.06% | 0.00% |
| Oct. 2, 2023 | Aziz Kabeer | Not found | S | Common Stock | 4770 | $16.07 | 2,475,310.0000 | 0 | 0.19% | 0.00% |
| Oct. 2, 2023 | Aziz Kabeer | Not found | S | Common Stock | 902 | $16.07 | 2,475,310.0000 | 0 | 0.04% | 0.00% |
| Sept. 29, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 83337 | $16.28 | 2,480,080.0000 | 0 | 3.25% | 0.00% |
| Sept. 29, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 15764 | $16.28 | 2,476,212.0000 | 0 | 0.63% | 0.00% |
| Oct. 2, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 4770 | $16.07 | 2,475,310.0000 | 0 | 0.19% | 0.00% |
| Oct. 2, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 902 | $16.07 | 2,475,310.0000 | 0 | 0.04% | 0.00% |
| Sept. 29, 2023 | Aziz Kabeer | Not found | S | Common Stock | 83337 | $16.28 | 2,480,080.0000 | 0 | 3.25% | 0.00% |
| Sept. 29, 2023 | Aziz Kabeer | Not found | S | Common Stock | 15764 | $16.28 | 2,476,212.0000 | 0 | 0.63% | 0.00% |
| Sept. 27, 2023 | Aziz Kabeer | Not found | S | Common Stock | 707 | $16.07 | 5,168,682.0000 | 0 | 0.01% | 0.00% |
| Sept. 27, 2023 | Aziz Kabeer | Not found | S | Common Stock | 134 | $16.07 | 5,168,682.0000 | 0 | 0.00% | 0.00% |
| Sept. 28, 2023 | Aziz Kabeer | Not found | S | Common Stock | 7160 | $16.11 | 5,168,682.0000 | 0 | 0.14% | 0.00% |
| Sept. 28, 2023 | Aziz Kabeer | Not found | S | Common Stock | 1356 | $16.11 | 5,168,682.0000 | 0 | 0.03% | 0.00% |
| Sept. 28, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 1356 | $16.11 | 2,580,083.0000 | 0 | 0.05% | 0.00% |
| Sept. 27, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 707 | $16.07 | 2,587,243.0000 | 0 | 0.03% | 0.00% |
| Sept. 27, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 134 | $16.07 | 2,581,439.0000 | 0 | 0.01% | 0.00% |
| Sept. 28, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 7160 | $16.11 | 2,580,083.0000 | 0 | 0.28% | 0.00% |
| Sept. 13, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 336 | $16.00 | 2,589,440.0000 | 0 | 0.01% | 0.00% |
| Sept. 13, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 64 | $16.00 | 2,589,440.0000 | 0 | 0.00% | 0.00% |
| Sept. 13, 2023 | Aziz Kabeer | Not found | S | Common Stock | 336 | $16.00 | 2,589,440.0000 | 0 | 0.01% | 0.00% |
| Sept. 13, 2023 | Aziz Kabeer | Not found | S | Common Stock | 64 | $16.00 | 2,589,440.0000 | 0 | 0.00% | 0.00% |
| Sept. 7, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 2841 | $16.05 | 2,589,840.0000 | 0 | 0.11% | 0.00% |
| Sept. 7, 2023 | Aziz Kabeer | Not found | S | Common Stock | 537 | $16.05 | 2,589,840.0000 | 0 | 0.02% | 0.00% |
| Sept. 7, 2023 | Aziz Kabeer | Not found | S | Common Stock | 2841 | $16.05 | 2,589,840.0000 | 0 | 0.11% | 0.00% |
| Sept. 6, 2023 | Aziz Kabeer | Not found | S | Common Stock | 598 | $16.02 | 2,590,377.0000 | 0 | 0.02% | 0.00% |
| Sept. 6, 2023 | Aziz Kabeer | Not found | S | Common Stock | 3164 | $16.02 | 2,592,681.0000 | 0 | 0.12% | 0.00% |
| Sept. 7, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 537 | $16.05 | 2,589,840.0000 | 0 | 0.02% | 0.00% |
| Sept. 6, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 598 | $16.02 | 2,590,377.0000 | 0 | 0.02% | 0.00% |
| Sept. 6, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 3164 | $16.02 | 2,592,681.0000 | 0 | 0.12% | 0.00% |
| Aug. 23, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 64 | $16.00 | 2,596,980.0000 | 0 | 0.00% | 0.00% |
| Aug. 23, 2023 | Aziz Kabeer | Not found | S | Common Stock | 336 | $16.00 | 2,596,980.0000 | 0 | 0.01% | 0.00% |
| Aug. 23, 2023 | Aziz Kabeer | Not found | S | Common Stock | 64 | $16.00 | 2,596,980.0000 | 0 | 0.00% | 0.00% |
| Aug. 23, 2023 | Adjuvant Global Health Technology Fund, L.P. | Not found | S | Common Stock | 336 | $16.00 | 2,596,980.0000 | 0 | 0.01% | 0.00% |
| Aug. 18, 2023 | RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | P | Common Stock | 1777778 | $9.00 | 5,551,295.0000 | 0 | 47.11% | 0.00% |
| June 7, 2023 | Marks Gilbert Lynn | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Martin Patricia A. | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Readnour Robin Shane | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Aziz Kabeer | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Zakrzewski Joseph S | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | FitzPatrick Margaret M | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Wong Stephanie | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | Spigelman Melvin K | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | Easom Eric | Chief Executive Officer | P | Common Stock | 10000 | $5.38 | 1,214,789.0000 | 0 | 0.83% | 0.00% |
| Feb. 23, 2023 | Easom Eric | Chief Executive Officer | A | Stock Option (right to buy) | 267650 | $0.00 | 267,650.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Eckburg Paul | Chief Medical Officer | A | Stock Option (right to buy) | 70950 | $0.00 | 70,950.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Chanda Sanjay | Chief Development Officer | A | Stock Option (right to buy) | 57950 | $0.00 | 57,950.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Day Lucy | Chief Financial Officer | A | Stock Option (right to buy) | 82300 | $0.00 | 82,300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Nazak Michael Adrian | Chief Accounting Officer | A | Stock Option (right to buy) | 16600 | $0.00 | 16,600.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Krause Kevin Michael | Chief Strategy Officer | A | Stock Option (right to buy) | 62200 | $0.00 | 62,200.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Eizen Joshua M | Chief Legal Officer | A | Stock Option (right to buy) | 50150 | $0.00 | 50,150.0000 | 0 | 9999.99% | 0.00% |